Zannes Timothy P 4
4 · bioAffinity Technologies, Inc. · Filed Apr 24, 2024
Insider Transaction Report
Form 4
Zannes Timothy P
Secretary, EVP, Gen. Counsel
Transactions
- Exercise/Conversion
Common Stock
2024-04-04$1.16/sh+64,848$75,224→ 75,155 total - Tax Payment
Common Stock
2024-04-04$2.58/sh−29,031$74,900→ 46,124 total - Exercise/Conversion
Stock Option (right to buy)
2024-04-04−64,848→ 0 totalExercise: $1.16Exp: 2024-04-28→ Common Stock (64,848 underlying)
Footnotes (2)
- [F1]Represents shares withheld to cover the exercise price of the options exercised.
- [F2]This option vested in 7 equal monthly installments beginning on April 28, 2014.